Sanofi SA (NASDAQ:SNY)
| 55.52 Delayed Data As of May 26 |  -0.33 / -0.59%Today’s Change | 46.93 Today|||52-Week Range 58.10 | +10.82% Year-to-Date |
SNY Special Dividend: SNY will begin trading ex-dividend today with a $0.2972 special dividend payable to shareholders of record as of 05/27/22.
Latest SNY News | Press Releases
| 5 Large-Cap Stocks to Buy Amid the Nasdaq’s Bear Market May 26 / StockNews.com - Paid Partner Content | The Zacks Analyst Blog Highlights Alphabet, UnitedHealth Group, Costco Wholesale, Cisco Systems and Sanofi May 24 / Zacks.com - Paid Partner Content |
| Why Regeneron Investors Shouldn't Fear Its Patent Cliff May 26 / MotleyFool.com - Paid Partner Content | Top Stock Reports for Alphabet, UnitedHealth & Costco May 23 / Zacks.com - Paid Partner Content |
| Biotech Stock Roundup: ETTX Up on Acquisition Deal, REGN Offers Updates May 25 / Zacks.com - Paid Partner Content | Sanofi, Regeneron's Dupixent Gets FDA Nod for 4th Indication May 23 / Zacks.com - Paid Partner Content |
| Sanofi, Regeneron's Dupixent Gets FDA Nod for 4th Indication (Revised) May 25 / Zacks.com - Paid Partner Content | This Safe Stock Is Dirt Cheap -- and It's Beating the Market May 20 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 55.85 |
| Today’s open | 55.39 |
| Day’s range | 55.28 - 55.73 |
| Volume | 55,398 |
| Average volume (3 months) | 2,147,572 |
| Market cap | $136.2B |
Data as of 4:00pm ET, 05/26/2022
Growth & Valuation
| Earnings growth (last year) | -47.56% |
| Earnings growth (this year) | -96.15% |
| Earnings growth (next 5 years) | +8.75% |
| Revenue growth (last year) | +8.63% |
| P/E ratio | 20.9 |
| Price/Sales | 2.82 |
| Price/Book | 1.74 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BMYBristol-Myers Squibb | +0.36 | +0.47% |
| GSKGlaxoSmithKline | -0.56 | -1.25% |
| NVONovo Nordisk | +1.39 | +1.32% |
| NVSNovartis | +0.01 | +0.01% |
Data as of 5:58pm ET, 05/26/2022
Financials
| Last reporting date | -- |
| EPS forecast (this quarter) | $0.70 |
| Annual revenue (last year) | $44.6B |
| Annual profit (last year) | $7.4B |
| Net profit margin | 16.48% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Paris, Ile-de-france |
Forecasts
